Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Johnson

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
BJS Open|November 18, 2021
Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50-60 kg/m2: 5-year outcomes of a double-blind, randomized clinical trialOdd Bjørn Kjeldaas Salte, Marius Svanevik, Hilde Risstad, et al.
Clinical Pharmacokinetics|November 22, 2023
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight IndividualsKine Eide Kvitne, Markus Hovd, Line Kristin Johnson, et al.
Scandinavian Journal of Gastroenterology|October 29, 2021
A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trialChrister Julseth Tønnesen, Jøran Hjelmesæth, Dag Hofsø, et al.
Journal of Pharmaceutical Sciences|October 22, 2020
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 EnzymesVeronica Krogstad, Alexandra Peric, Ida Robertsen, et al.
Clinical Pharmacokinetics|March 29, 2023
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral ClearanceMarkus Hovd, Ida Robertsen, Line Kristin Johnson, et al.
The Lancet. Diabetes & Endocrinology|November 4, 2019
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trialDag Hofsø, Farhat Fatima, Heidi Borgeraas, et al.
BMJ Open|May 31, 2018
Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)Jøran Hjelmesæth, Anders Åsberg, Shalini Andersson, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2025
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trialJostein Wågen Hauge, Heidi Borgeraas, Kåre Inge Birkeland, et al.
Elife|January 28, 2016
Epigenetic regulation of hematopoiesis by DNA methylationAniket V Gore, Brett Athans, James R Iben, et al.
JAMA Surgery|July 3, 2024
Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled TrialCecilia Karlsson, Line Kristin Johnson, Peter J Greasley, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
BJS Open|November 18, 2021
Standard versus distal Roux-en-Y gastric bypass in patients with BMI 50-60 kg/m2: 5-year outcomes of a double-blind, randomized clinical trialOdd Bjørn Kjeldaas Salte, Marius Svanevik, Hilde Risstad, et al.
Clinical Pharmacokinetics|November 22, 2023
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight IndividualsKine Eide Kvitne, Markus Hovd, Line Kristin Johnson, et al.
Scandinavian Journal of Gastroenterology|October 29, 2021
A novel intragastric balloon for treatment of obesity and type 2 diabetes. A two-center pilot trialChrister Julseth Tønnesen, Jøran Hjelmesæth, Dag Hofsø, et al.
Journal of Pharmaceutical Sciences|October 22, 2020
Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 EnzymesVeronica Krogstad, Alexandra Peric, Ida Robertsen, et al.
Clinical Pharmacokinetics|March 29, 2023
Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral ClearanceMarkus Hovd, Ida Robertsen, Line Kristin Johnson, et al.
The Lancet. Diabetes & Endocrinology|November 4, 2019
Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trialDag Hofsø, Farhat Fatima, Heidi Borgeraas, et al.
BMJ Open|May 31, 2018
Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)Jøran Hjelmesæth, Anders Åsberg, Shalini Andersson, et al.
The Lancet. Diabetes & Endocrinology|April 4, 2025
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trialJostein Wågen Hauge, Heidi Borgeraas, Kåre Inge Birkeland, et al.
Elife|January 28, 2016
Epigenetic regulation of hematopoiesis by DNA methylationAniket V Gore, Brett Athans, James R Iben, et al.
JAMA Surgery|July 3, 2024
Gastric Bypass vs Diet and Cardiovascular Risk Factors: A Nonrandomized Controlled TrialCecilia Karlsson, Line Kristin Johnson, Peter J Greasley, et al.
Pageof 7